Form 8-K - Current report:
SEC Accession No. 0001558370-21-000974
Filing Date
2021-02-12
Accepted
2021-02-12 16:30:39
Documents
3
Period of Report
2021-01-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20210128x8k.htm 8-K 28816
2 EX-10.1 tmb-20210128xex10d1.htm EX-10.1 77483
3 GRAPHIC tmb-20210128xex10d1001.jpg GRAPHIC 631
  Complete submission text file 0001558370-21-000974.txt   108566
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

EIN.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39619 | Film No.: 21628136
SIC: 2836 Biological Products, (No Diagnostic Substances)